首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Current treatment options in oncology

缩写:CURR TREAT OPTION ON

ISSN:1527-2729

e-ISSN:1534-6277

IF/分区:5.8/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1309
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Jing Su,Meiyuan Jin,Zengwu Shao et al. Jing Su et al.
Malignant tumors of the distal tibia are rare and pose unique reconstructive challenges due to the region's complex anatomical and biomechanical characteristics. Contemporary treatment has progressively shifted from amputation to limb salva...
Marina Tsoli,Anat Bel-Ange,Karine Atlan et al. Marina Tsoli et al.
The adrenocorticotropic hormone (ACTH)-secreting neuroendocrine neoplasms (NENs) represent a rare but frequently severe disease that is associated with poor prognosis, if not adequately managed. Treatment strategies vary according to the ch...
Piotr Remiszewski,Agata Pisklak,Kinga Filipek et al. Piotr Remiszewski et al.
Dermatofibrosarcoma protuberans (DFSP) is a rare soft tissue sarcoma with an incidence of 0.008 to 0.045 cases per 100,000 per year, accounting for less than 1% of all soft tissue sarcomas. It mainly affects adults aged 30-50 years, usually...
Piotr Remiszewski,Joanna Taczała,Marcin Rosiński et al. Piotr Remiszewski et al.
Dermatofibrosarcoma protuberans (DFSP) is a rare, low-grade mesenchymal neoplasm that arises in the dermis and subcutaneous tissue. Clinically, DFSP presents as a slow-growing cutaneous plaque or nodular mass that is often initially mistake...
Lingbin Meng,Adam Khorasanchi,Rohit Jain Lingbin Meng
The management of muscle-invasive bladder cancer (MIBC) is evolving rapidly, with the integration of neoadjuvant and adjuvant therapies and biomarker-driven patient selection now essential to refining treatment decisions. While cisplatin-ba...
Taku Fujimura,Yoshihide Asano Taku Fujimura
Plasminogen activator inhibitor-1 (PAI-1) plays a multifaceted and central role in the tumor biology of various skin malignancies. Beyond its classical function in fibrinolysis, PAI-1 contributes to tumor progression by promoting immunosupp...
Ojbindra Kc,Moataz Ellithi,Vijaya Raj Bhatt Ojbindra Kc
Older adults with acute myeloid leukemia (AML) face disproportionately poor outcomes, driven by a combination of high-risk disease biology and functional vulnerabilities that are often overlooked by conventional oncology assessments. Geriat...
Siyuan Cui,Kui Zhao,Na Wang et al. Siyuan Cui et al.
Novel strategies utilizing immune checkpoint inhibitors (ICIs) have emerged over the past several years and substantially changed the treatment landscape of advanced gastric cancer (GC). Based on the encouraging results achieved, numerous c...
Vinita Popat,Ernest Han Vinita Popat
Ovarian cancer, particularly high-grade serous carcinoma (HGSC), remains a leading cause of mortality in gynecologic oncology. Emerging research identifies serous tubal intraepithelial carcinoma (STIC) as a precursor lesion in many HGSC cas...
Jerry T Wu,Elizabeth Nowak,Jarrell Imamura et al. Jerry T Wu et al.
Undifferentiated pleomorphic sarcoma (UPS) and myxofibrosarcoma (MFS) are among the most common adult soft tissue sarcoma (STS) subtypes. Due to their high genetic complexity, heterogeneity, and lack of specific genetic alterations, no cons...